Notice of Intent to Sole Source - Chemistry Center for Combating Antibiotic-Resistant Bacteria (CC4CARB)
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
NATIONAL INSTITUTES OF HEALTH NIAID
Contract Value
Not provided
Codes & Classification
Solicitation Number
75N93024R00022
NAICS
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Classification Code
AN12
Additional Details
Documents4
The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), has issued a Special Notice of Intent to Sole Source for the continuation of the Chemistry Center for Combating Antibiotic-Resistant Bacteria (CC4CARB). This procurement, identified under solicitation number 75N93024R00022, is focused on advancing research and development efforts to address the critical public health challenge posed by antibiotic-resistant bacteria, with a particular emphasis on Gram-negative pathogens and other organisms identified as Antimicrobial Resistance (AMR) threats.
The primary objective of this contract is to support the comprehensive coordination and execution of activities related to the design, synthesis, in vitro testing, and distribution of chemical libraries. These libraries will consist of discrete natural products and small molecules with diverse physicochemical properties, specifically engineered to target antibiotic-resistant bacteria. The scope of work is organized into four key functional areas:
1. **Library Design**: Development of chemical libraries tailored to address the unique challenges of antibiotic resistance, ensuring diversity and relevance to current AMR threats.
2. **Compound Synthesis**: Production of the designed compounds, leveraging advanced synthetic chemistry techniques to generate high-quality, well-characterized molecules.
3. **Compound Testing**: In vitro evaluation of synthesized compounds to assess their efficacy and potential as therapeutic agents against targeted bacterial pathogens.
4. **Compound Management**: Oversight of compound inventory, distribution, and data management to facilitate broad access and efficient utilization of the chemical libraries.
Additionally, the contract encompasses robust project management responsibilities to ensure seamless integration and oversight across all technical areas.
The place of performance for this effort is Rockville, Maryland, USA. The procurement is classified under NAICS code 541714 (Research and Development in Biotechnology, except Nanobiotechnology), with a Product Service Code of AN12. The contracting activity is managed by the NIH NIAID Office, a federal entity within the Department of Health and Human Services.
Interested and responsible offerors are invited to submit proposals, which will be duly considered by the agency. The official Request for Proposals (RFP) will be available electronically on April 8, 2026, via https://sam.gov/. Proposals must be submitted online through the NIAID electronic Contract Proposal Submission (eCPS) system; submissions via facsimile or email will not be accepted. Detailed instructions for using the eCPS platform are available at https://ecps.nih.gov/ under the "How to Submit" section.
It is important to note that this notice does not obligate the government to award a contract, nor will collect calls or facsimile transmissions be accepted in relation to this solicitation. For technical issues accessing the RFP, users are advised to open the document in Adobe Acrobat via the Chrome browser to ensure all embedded links function correctly.
For further information or inquiries, the primary point of contact is Ignacio Reyes, Contracting Officer ([email protected], 301-435-7574), with Jonathan Bryan ([email protected], 240-669-5180) serving as the secondary contact.
This opportunity represents a significant and ongoing federal investment in combating antibiotic resistance through innovative chemical biology and drug discovery efforts. Contractors with demonstrated expertise in chemical library design, synthesis, biological testing, and compound management—particularly in the context of antimicrobial research—are encouraged to review the solicitation and consider participation.